Xinqiao Hospital Of Chongqing
Clinical trials sponsored by Xinqiao Hospital Of Chongqing, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple CT scan be enough to decide stroke treatment? Results expected Jun 2027 (estimated)
-
MRNA cancer therapy takes on blood tumors
Disease control Recruiting nowThis early-phase trial is testing an experimental mRNA-based drug that turns the body's own cells into cancer fighters. The drug targets CD19, a protein found on certain blood cancer cells. Researchers will enroll 47 adults with B-cell lymphoma or leukemia who have run out of sta…
Early phase 1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for Late-Stroke patients: drug before procedure may boost recovery
Disease control Recruiting nowThis study tests whether giving a clot-busting drug (rhTNK-tPA) before a clot-removal procedure helps stroke patients who arrive 4.5 to 24 hours after symptoms start. About 820 adults with a blocked large artery in the brain will receive either the drug or a placebo. The goal is …
Phase 3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a simple CT scan be enough to decide stroke treatment?
Knowledge-focused Recruiting nowThis study tests whether a simple CT scan (NCCT) works as well as advanced imaging (CTP/MRI) for choosing stroke patients who need emergency clot removal. About 1,846 adults with acute stroke arriving within 24 hours of symptoms will be enrolled. The goal is to see if the simpler…
Sponsor: Xinqiao Hospital of Chongqing • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC